Page 1 (0s)
ogt%-vurn/-4—. Reference : Herman WH, Ilag LL, Johnson, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injection in older adults with type 2 diabetes. Diabetes Care. 2005;28:1568-1573 Rosenstock J. Ahmann AJ, Colon G, Scism Bacon J, Jiang H, Martin S. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/ lispro ) versus basal bolus (glargine/ lispro ) therapy. Diabetes Care . 2008:31:20-25.
Page 2 (12s)
aorta BASAGLAR'• -100 47 c. 90 Years of Milestones 1920s 1940 1982 1996 2014 Discovery and marketing of the first IRT' Synthesis Of the first slower-acting insulin (NPH)' First recombinant human insulins marketed' First rapid-acting insulin analog approved (lisproy First biosimilar basal insulin analog (glargine) approve&.
Page 3 (23s)
There is alvvays a prernix insulin for every patient.
Page 4 (33s)
Graphical user interface, text Description automatically generated with medium confidence.